GENE ONLINE|News &
Opinion
Blog

Celltrion
Trials & Approvals Biosimilar
Celltrion’s Avastin Biosimilar Gets FDA Greenlight
2022-09-29
Technology COVID-19 Variant
Celltrion’s New Antibody Is Effective against the Omicron Variant
2022-01-06
COVID-19 Antibody Therapy
Korea’s Celltrion Pushes for Broader Use of COVID-19 Treatment both Domestically And Abroad
2021-08-12
COVID-19 Immunoassay
Celltrion Bags FDA’s Emergency Approval for COVID-19 Rapid Test, Prepares to Ship Supply to the US
2021-04-21
Two South Korean Companies Look to Capture the Biosimilars Market Worth Billions
2020-12-01
COVID-19 Antibody Therapy
Celltrion Announces Positive Phase 1 Results for COVID-19 Antibody Therapy
2020-11-12
Licensing Crohn’s disease
Spotlight: Celltrion Healthcare’s Remsima Expands to Multiple Medical Uses
2020-07-20
LATEST
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
2023-03-24
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Shining a Light on Oncology with Rakuten Medical Co-CEO Takashi Toraishi
2023-03-23
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
FDA Extends Approval Of Regeneron’s Evkeeza For Inherited High Cholesterol
2023-03-23
Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.
2023-03-23
READ MORE
EVENT
2023-03-28
Reuters Events: Pharma USA 2023
Philadelphia, USA
2023-04-24
Cell & Gene Therapy Summit 2023
Brussels, Belgium
2023-04-28
Boston Chinese Investment Club 2023 Biotech Pitch Competition
Boston, USA
2023-11-16
3rd INTERNATIONAL CONFERENCE ON NUTRITION AND HEALTHCARE
Dubai, UAE
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top